Next generation sequencing based coronary heart disease genetic risk evaluation method
A genetic risk assessment and next-generation sequencing technology, applied in the field of coronary heart disease risk assessment based on next-generation sequencing, can solve problems such as the lack of a good genetic risk assessment method for coronary heart disease.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0028] The above solution will be further described below in conjunction with specific embodiments. It should be understood that these examples are used to illustrate the present invention and not to limit the scope of the present invention. The implementation conditions used in the examples can be further adjusted according to the conditions required by specific applications, and the unspecified implementation conditions are usually the conditions in routine experiments.
[0029] The concrete method of a kind of coronary heart disease risk assessment method of the present invention is as follows:
[0030](1) Selection and weighting of risk SNPs. 风险SNPs位点有两个来源:第一,已知风险SNPs位点,包括rs646776,rs17114036,rs11206510,rs17465637,rs6725887,rs9818870,rs17609940,rs9349379,rs12190287,rs3798220,rs10455872,rs11556924,rs4977574,rs9411489,rs1746048, rs12413409, rs964184, rs2259816, rs3184504, rs4773144, rs2895811, rs3825807, rs12936587, rs216172, rs46522, rs1122608, rs9982601; Second, deep minin...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com